Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
24 hedge funds and large institutions have $2.76M invested in Histogen Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
28% more capital invested
Capital invested by funds: $2.15M → $2.76M (+$611K)
9% more funds holding
Funds holding: 22 → 24 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.83M |
| 2 |
Renaissance Technologies
New York
|
+$373K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.8K |
| 4 |
VF
Virtu Financial
New York
|
+$18.6K |
| 5 |
Jane Street
New York
|
+$16.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$94K |
| 2 |
N
Natixis
Paris,
France
|
-$60K |
| 3 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$30.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$22.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$57 | -5 | -31% |
|
27
Morgan Stanley
New York
| – | -$34 | -3 | Closed |
|
|
EI
28
Ellevest Inc
New York
| – | +$11 | +1 | New |
|
|
TSWM
29
Tyler-Stone Wealth Management
Beachwood,
Ohio
| – | +$57 | +5 | New |
|
|
CLOS
30
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | +$172 | +15 | New |
|
HSTO Hedge Fund Activity: Q4 2021 in Review
24 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2021, worth a combined $2.76M — up 28% from $2.15M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new HSTO positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $2.83M. The largest seller was Meitav Investment House, exiting entirely with an estimated $94K sold.
- 24 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2021, up from 22 in Q3 2021.
- Funds reported $2.76M of Histogen Inc. Common Stock stock for Q4 2021, up 28% quarter-over-quarter.
- 8 funds opened new Histogen Inc. Common Stock positions in Q4 2021 and 6 closed out, a net change of +2 holders.
- The largest Histogen Inc. Common Stock buyer in Q4 2021 was Armistice Capital, an estimated $2.83M added.
- The largest Histogen Inc. Common Stock seller in Q4 2021 was Meitav Investment House, an estimated $94K sold.
Based on aggregated 13F filings for Q4 2021.